We launch big ideas
We partner with inventors, universities, and entrepreneurs to launch big ideas. A holistic approach to public venture capital in which everyone involved does better.
Cue Biopharma Inc
Selectively modulating T-cells to fight cancer.
Cue Biopharma (NASDAQ: CUE), a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T-cells directly within the body to transform the treatment of cancer, infectious diseases, and autoimmune diseases.
Intercepting and preventing immune-related diseases
Provention Bio (NASDAQ: PRVB), is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threating immune-mediated diseases.
Delivering nanosecond pulses of energy to non-thermal cells
Pulse Biosciences (NASDAQ: PLSE), is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients.